Evidence map›Paper›PMID 37369775›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024

Neurosteroids: mechanistic considerations and clinical prospects.

Jamie L Maguire, Steven Mennerick

Open access · hybridAbstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Do sex and gender matter in the pharmacological treatment of depression?Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  8. GABAFrontiers in pharmacology · 2026
    Review
  9. Review
  10. Review
  11. Review
  12. Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jamie L MaguireDepartment of Neuroscience, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA, 02111, USA.ORCID 0000-0002-4085-8605
Steven MennerickDepartment of Psychiatry and Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis School of Medicine, 660 S. Euclid Ave., St. Louis, MO, 63110, USA. menneris@wustl.edu.ORCID 0000-0003-0868-0664
Tufts University · USWashington University in St. Louis · US

Funding

Neuroactive steroids as novel psychiatric treatments: mechanistic studiesP50MH122379 · NIMH · WASHINGTON UNIVERSITY · PI COVEY, DOUGLAS F · 2021 to 2025
$12.2M
Investigating the pathological consequences of seizure-induced activation of the HPA axisR01NS102937 · NINDS · TUFTS UNIVERSITY BOSTON · PI Jamie Lynn Maguire · 2017 to 2026
$4.2M
Stress-induced impairments in endogenous neurosteroid signaling in the BLA negatively impacts network and behavioral statesR01MH128235 · NIMH · TUFTS UNIVERSITY BOSTON · PI MAGUIRE, JAMIE LYNN · 2021 to 2025
$2.5M
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUSR01MH123748 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2021 to 2025
$2.4M
Interneurons tune the neural circuits mediating the anxiolytic effects of alcoholR01AA026256 · NIAAA · TUFTS UNIVERSITY BOSTON · PI MAGUIRE, JAMIE LYNN · 2018 to 2022
$1.9M
NIAAA NIH HHS R01 AA026256NIMH NIH HHS P50 MH122379NIMH NIH HHS R01 MH123748NIMH NIH HHS R01 MH128235NINDS NIH HHS R01 NS102937
6 · The paper itself

Abstract

Like other classes of treatments described in this issue's section, neuroactive steroids have been studied for decades but have risen as a new class of rapid-acting, durable antidepressants with a distinct mechanism of action from previous antidepressant treatments and from other compounds covered in this issue. Neuroactive steroids are natural derivatives of progesterone but are proving effective as exogenous treatments. The best understood mechanism is that of positive allosteric modulation of GABA

Indexed as

NeurosteroidsAntidepressive AgentsBrainProgesteroneReceptors, GABA-AAntidepressive AgentsNeurosteroidsProgesteroneReceptors, GABA-A

Identifiers

PMID37369775
PMCPMC10700537
OpenAlexW4382344266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.